PubMed HealthSearch

PubMed · 934038

Cardiac output measurement by thermodilution: methodologic problems.

Abstract

In clinical practice, thermodilution technique for cardiac output measurement is generally applied to the right heart (injection of a saline cold bolus in the right atrium, temperature measurement downstream in the pulmonary artery). This technique is well adapted to repetitive measurements using a single catheter. However, its validity is dependent on several methodologic requirements: quantitation of the indicator, control of the catheter's dead-space effect, conservation and mixing of the cold bolus, accurate measurement of small thermal gradients. Calculations from the thermal dilution curve must be adapted to possible baseline shifts. All these different methodologic aspects are studied. Several solutions (heat exchanger, automatic injection, calculation method) are proposed. Comparison between an automatic thermodilution device and dye dilution has been performed successfully.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A Saadjian, J E Quercy, J Torresani. 1976-04-30. Cardiac output measurement by thermodilution: methodologic problems.. https://pubmed.ncbi.nlm.nih.gov/934038/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Pathophysiology and prognostic significance of Holter-detected ST segment depression after myocardial infarction. The Tissue Plasminogen Activator: Toronto (TPAT) Study Group.

OBJECTIVES: We performed Holter monitoring on days 4 and 7 after acute myocardial infarction in 109 patients to assess whether ST segment shift would identify those with more severe coronary artery disease, left ventricular dysfunction and unfavorable prognosis. BACKGROUND: Silent myocardial ischemia is a frequent and prognostically significant event after acute myocardial infarction. However, the specific pathophysiologic mechanisms and the impact of thrombolytic therapy are uncertain. METHODS: In addition to Holter monitoring, patients underwent exercise testing, radionuclide angiography on days 1 and 9 and quantitative coronary angiography on day 9. RESULTS: Thirty-five patients (32%) had ST segment depression and had similar recombinant tissue-type plasminogen activator (rt-PA) treatment assignment and a reduced cross-sectional area of the infarct-related artery (0.59 +/- 0.57 vs. 1.04 +/- 1.26 mm2, p < 0.05). Global left ventricular function improved from day 1 to day 9 in patients without (4% +/- 11%, p < 0.001) but not in those with (0% +/- 7%) ST segment depression. In-hospital event rates were similar; however, follow-up 18 +/- 11 months after hospital discharge revealed a greater frequency of death and recurrent myocardial infarction in patients with compared with those without ST segment depression (27% vs. 6%, p = 0.03). CONCLUSIONS: After acute myocardial infarction, approximately one third of patients have ST segment depression on Holter monitoring, independent of the use of thrombolytic therapy. The unfavorable prognosis observed in these patients may be related to greater lumen obstruction in the infarct-related artery and lack of improvement in left ventricular function.

Cardiac Catheterization